Curis Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (39)

Latest Posts

About This Stock More About This Stock
2 Names To Consider In A Heating Up Small-Cap Biotech Sector
Article By: Scott Matusow
Wednesday, November 27, 2019 8:30 AM EDT
The biotech sector has been heating up due to an increased risk appetite coming from additional market liquidity and a favorable Fed policy. Here, we highlight 2 early-stage biotech companies that we think can provide substantial upside.
In this article: CALA, CRIS Also: INCY, PFE, AZN, CNST, KRTX, NXTC
Read
Biotech Winners 2015: Rayno Mid Caps Were Up 29.6%
Article By: Rod Raynovich
Sunday, January 3, 2016 10:00 PM EDT
We previously reviewed the Rayno Small Cap Portfolio which was up 38.1% in Q4 2015 and the Mid-Caps also beat despite a big loss by Clovis Oncology after the FDA required more data on its lung cancer drug.
In this article: MRK, CRIS, GERN, IBB, REGN, SGEN, ALKS, CBST, CLVS, VRTX, PCYC, XLV, ABBV
Read
Rayno Small Cap Biopharmaceutical Portfolio 2015 In Rally Mode - XBI Up 2.5%
Article By: Rod Raynovich
Tuesday, December 29, 2015 9:44 PM EDT
We recommended three new small caps at the October Bioinvestor Forum: Curis, Geron and Ocera Therapeutics. This forum offers the best window on emerging small companies in the fall, a good time to get a head start on biotech small cap investing.
In this article: ARRY, CRIS, GERN, XBI, IMMY, GLYC, FCSC, RXDX, OCRX
Read
2015 Life Science Sector Review As Biopharma Rally Fades
Article By: Rod Raynovich
Monday, December 28, 2015 8:00 PM EDT
This is not a good week for trading. Portfolio managers are re-jiggering positions so you may not see the trends correctly. Many biotech stocks started rallying off the bottom in October then again around December 11.
In this article: CRIS, GERN, REGN, SGEN, ALKS, BIIB, CLVS, PCYC, XBI, XLV, ABBV, CMRX, FCSC, RXDX
Read
Rayno Small Caps Outperform: New Long Idea - Imprimis Pharmaceuticals
Article By: Rod Raynovich
Tuesday, December 1, 2015 7:00 PM EDT
Today we added a new small cap speculative pick, Imprimis Pharmaceutical, an emerging pharmaceutical Company focused on developing and commercializing proprietary compounded, customized drug therapies to physicians and patients in the US.
In this article: ARRY, CRIS, GERN, IMMY, GLYC, FCSC, RXDX
Read

PARTNER HEADLINES

Latest Tweets for $CRIS

No tweets yet!